How soon after taking Wegovy do side effects start?

Side effects are most common in the first one to two weeks after each new dose, then generally settle — not a reason to stop without speaking to your prescriber first.
Gastrointestinal symptoms (nausea, loose stools, indigestion) make up most of what people notice; they reflect semaglutide slowing gastric emptying, not an allergic reaction.
Severe or persistent stomach pain radiating to the back requires urgent medical attention, the MHRA highlighted acute pancreatitis as an infrequent but serious risk in a January 2026 Drug Safety Update.
Any suspected side effect, or any concern about a medicine you have bought online, can be reported directly to the MHRA via the Yellow Card scheme.

Most people notice Wegovy side effects within the first day or two of their initial injection. Nausea is the most commonly reported symptom and typically appears within 24 to 48 hours of the first dose, often peaking around the day after the injection. For many people, symptoms ease within a week or two as the body adjusts. Because Wegovy (semaglutide) is a prescription-only medicine, a GPhC-registered prescriber assesses every person individually before treatment begins — timing and intensity of side effects can vary meaningfully from one patient to another, so understanding what to expect, and when to act, is an important part of starting safely. You can find a broader overview on our Wegovy side effects page if you want the fuller picture.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

A practical guide to when Wegovy side effects appear, and what shapes the timeline

Step 1: the first 24 to 48 hours after your injection

The single question our prescribers hear most weeks is some version of this one: "When will I feel something?" If you are wondering how soon you get side effects from Wegovy, the honest answer is that nausea, if it is going to happen, tends to arrive within the first day or two of the initial 0.25 mg dose. Semaglutide slows the rate at which food leaves the stomach and acts on appetite-signalling pathways in the brain, and that combination can make the digestive system feel unsettled before it acclimatises.

Other early symptoms include mild indigestion, a feeling of fullness after very small amounts of food, and occasionally loose stools or constipation. Headache and fatigue are also reported in this window, though less reliably. The NHS patient information for semaglutide lists these as common effects, meaning they affect more than one in ten people at some point during treatment.

Eating a smaller meal before the injection, staying well hydrated, and avoiding rich or fatty food in the hours afterwards are practical steps many people find useful. These are not prescriber instructions for your individual dose; they are general habits worth discussing when you start your consultation.

Step 2: the dose-increase window, why symptoms often return

The titration schedule for Wegovy moves up roughly every four weeks, stepping through 0.5 mg, 1.0 mg, 1.7 mg and then 2.4 mg maintenance. Each time the dose increases, a proportion of people notice a short recurrence of the nausea or loose stools they thought they had moved past.

This is not a sign that something has gone wrong. The body has adapted to the previous level; the new dose temporarily shifts the balance again, and understanding how soon Wegovy side effects tend to appear at each new dose can help you feel more prepared for each transition. Our Wegovy treatment guide covers the full titration schedule in more detail.

Some people tolerate every dose increase without much difficulty; others find 1.7 mg or 2.4 mg the hardest transition. Both patterns are normal. What matters clinically is whether side effects are manageable and temporary, or severe and prolonged. A prescriber can consider a slower titration pace if the standard schedule is proving difficult, that is a clinical conversation, not something to self-manage by skipping doses.

Step 3: the longer picture, what tends to settle and what does not

For the majority of people, the gastrointestinal side effects of Wegovy are front-loaded. Knowing how soon after starting Wegovy side effects typically ease can be reassuring, as the roughest stretch is usually weeks one to four, with each subsequent dose increase bringing a shorter and milder repeat. By the time maintenance dose is reached, many people report that their digestion has largely normalised, even at 2.4 mg or the newer 7.2 mg dose.

Injection-site reactions (redness, itching or a small lump at the site) can occur at any stage and tend to resolve within a day or two. Rotating between the abdomen, thigh and upper arm reduces the chance of localised irritation building up.

Some people notice a persistent change in taste, reduced appetite for foods they previously enjoyed, or reflux that does not fully settle. These effects are worth mentioning at review rather than pushing through alone. If you have questions between appointments, the aftercare team at nume is available seven days a week. You can also read more about one specific and sometimes overlooked symptom on our Wegovy and cough page.

When to get medical help straight away

Most Wegovy side effects are uncomfortable rather than dangerous. A small number of symptoms require prompt medical attention and should not be waited out.

Contact 111 or your GP, or go to A&E if severe, for: severe stomach pain that reaches through to the back, with or without vomiting, this may indicate acute pancreatitis, which the MHRA flagged in a formal safety update in January 2026 as an infrequent but serious risk with GLP-1 medicines. Also seek urgent help for: signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing, rapid heartbeat), symptoms of gallbladder problems (sudden pain in the upper right abdomen, especially after eating), or severe and persistent vomiting that is preventing you from keeping fluids down, this can lead to dehydration and put strain on the kidneys.

Low mood or thoughts of self-harm should also be reported to a healthcare professional without delay. These are listed on the NHS semaglutide page as symptoms requiring immediate attention. If you want to explore treatment options or have a clinical question before committing to anything, our prescribers discuss suitability and likely side-effect profile as a normal part of the free consultation. You can also read more about the broader experience of starting treatment on our weight-loss treatments overview.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions